Medicus Pharma Ltd.

NasdaqCM:MDCX Stock Report

Market Cap: US$78.9m

Medicus Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:MDCX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Nov 24BuyUS$406,397James QuinlanIndividual98,760US$4.12
15 Nov 24BuyUS$406,397Edward BrennanIndividual98,760US$4.12
28 Jun 24BuyUS$1,527James QuinlanIndividual622.5US$2.45
28 Jun 24BuyUS$2,490Francis LavelleIndividual622.5US$4.00
28 Jun 24BuyUS$2,291Erica MonacoIndividual934US$2.45
28 Jun 24BuyUS$381Carolyn BonnerIndividual155.5US$2.45
28 Jun 24BuyUS$4,583RBx Capital LPCompany1,868US$2.45

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MDCX?
Owner TypeNumber of SharesOwnership Percentage
General Public1,009,7078.61%
Hedge Funds1,266,00010.8%
Institutions1,774,08615.1%
VC/PE Firms3,707,50331.6%
Individual Insiders3,969,48433.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 45.2%.

Top Shareholders

Top 19 shareholders own 91.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.9%
Velocity Fund Management
2,914,330US$19.6m0%no data
17.1%
Ajay Raju
2,000,000US$13.5m0%no data
14.2%
Interchange Capital Partners, LLC
1,661,871US$11.2m14.1%2.89%
10.8%
Armistice Capital LLC
1,266,000US$8.5m0%0.22%
6.83%
John Hathaway
800,952US$5.4m0%no data
6.76%
RBx Capital LP
793,173US$5.3m0%100.0%
3.81%
Louis Falo
446,763US$3.0m0%no data
3.49%
Kenneth Melani
409,411US$2.8m0%no data
1.1%
James Quinlan
129,147US$869.2k0%no data
0.74%
Edward Brennan
86,500US$582.1k0%no data
0.48%
Private Advisor Group, LLC
56,750US$381.9k0%no data
0.33%
Erica Monaco
38,434US$258.7k0%no data
0.25%
Patriot Investment Management Group Inc
29,203US$196.5k0.34%0.01%
0.22%
Francis Lavelle
25,622US$172.4k0%no data
0.18%
UBS Asset Management AG
21,262US$143.1k0%no data
0.16%
Carolyn Bonner
18,905US$127.2k0%no data
0.11%
Robert Ciaruffoli
12,500US$84.1k0%no data
0.043%
Osaic Wealth, Inc. , Asset Management Arm
5,000US$33.7k0%no data
0.011%
William Ashton
1,250US$8.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 07:48
End of Day Share Price 2025/05/16 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medicus Pharma Ltd. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaBrookline Capital Markets
Jason KolbertD. Boral Capital LLC.
Jason McCarthyMaxim Group